News
Paris-based start-up Sonio raises US$14m to kick-start US expansion

The French software development company Sonio has secured US$14m to start the commercial development of its AI prenatal screening assistant in the US.
The “AI-powered” solution aims to automate ultrasound reporting and guide practitioners during foetal ultrasounds.
According to its developers, Sonio is the only SaaS platform that empowers healthcare professionals to secure prenatal care by combining technological innovation, medical expertise, and collective intelligence.
The platform, its founders argue, provides an AI software that associates the knowledge of prenatal medicine practitioners with all types of medical, imaging, genetic and environmental data to “optimise” prenatal screening and diagnosis.
The fundraising, led by North American impact fund Cross Border Impact Ventures and the Elaia funds, will support the Paris-based company to kick off the commercial development of its platform in the US and ramp up sales in Europe and India.
The funds will also fuel improvements to the SaaS solution and adapt its technology for the use of portable ultrasound scanners “providing image quality control and detection of potential anomalies”.
“Sonio has created an innovative platform that empowers foetal ultrasound technology, enhancing the effectiveness and efficiency of foetal medicine specialists,” commented Annie Thériault, managing partner at Cross-Border Impact Ventures.
“Additionally, it aims to bridge the increasing shortage of specialised healthcare workers worldwide. We take pride in leading this significant round of financing, as it contributes to the early growth of this venture.”
Cécile Brosset, CEO and co-founder of Sonio, said: “By supporting our technological and commercial growth, it makes it possible to achieve our mission. I am fortunate to be surrounded by a team of deeply committed experts, and I would like to thank them.
“Our board of directors is today in the image of Sonio, inscribed in the diversity of men and women, international, and in search of a model of both impact and growth.
“In a financing universe largely dominated by men, I am delighted to have found partners so aligned with our ambitions and who understood and valued Sonio’s mission as well as its strategy and rapid execution capacity.”
Events
Meet the shortlist: Company of the Year

The third annual Femtech World Awards ceremony is almost here. And today, we’re excited to reveal the shortlist for Company of the Year, sponsored by Femovate.
This award exists to recognise a company that doesn’t just build a product, but shifts the entire landscape of women’s health.
The winner will be an organisation that has demonstrated exceptional leadership in addressing women’s health needs through groundbreaking products, services, or platforms – one that is not only advancing care today but actively shaping the future of global femtech.
Femovate, our sponsor for this category, knows this territory well.
As the global femtech incubator and a true catalyst for change in women’s health, Femovate uses design to fuel innovation across every stage of a woman’s health journey, from proactive prevention to early detection and personalised treatment.
With over US$2 million in design capital invested, 30 products launched, and 7 FDA clearances supported across their portfolio, they are uniquely placed to champion the kind of bold, rigorous company-building this award celebrates.
Congratulations to the shortlist and thank you to everyone who entered or nominated.
Company of the Year Shortlist

Founded by physicist Dr Elina Berglund Scherwitzl, Co-Founder and CEO, Natural Cycles created the world’s first FDA-cleared and CE-marked contraceptive app, establishing digital contraception as a credible and regulated category in women’s healthcare.
Achieving these clearances required extensive clinical trials and rigorous scientific validation, setting a new benchmark for digital products in the femtech space.
In doing so, Natural Cycles helped define the regulatory pathway for the industry — meaning any company looking to develop digital contraceptives today must meet the same high scientific and regulatory standards that Natural Cycles pioneered.

ŌURA, the creator of Oura Ring, stands at the forefront of global femtech, redefining how women understand and manage their health through continuous innovation, research, and responsible AI.
Oura exemplifies what it means to drive meaningful impact in a historically underserved space by delivering personalised insights across women’s health – from menstruation, to pregnancy, perimenopause, and beyond.
That leadership is visible across ŌURA’s growing women’s health ecosystem. Features such as Cycle Insights, Period Prediction, Fertile Window, and Pregnancy Insights are designed to help women interpret changes across different life stages using continuous signals including temperature trends, sleep, stress, activity, and recovery.
Rather than offering one-size-fits-all tracking, ŌURA brings context to the complexity of women’s physiology—helping members see how hormonal shifts can shape readiness, sleep quality, recovery, and daily wellbeing.

Youterus Health is transforming how uterine health is understood, diagnosed, and treated across underserved markets.
Operating at the intersection of research, technology, and care delivery, the company has built an integrated platform that converts women’s lived experiences into structured health data, enabling earlier diagnosis, improved care pathways, and more equitable access to treatment,
At the core of this innovation is the WOMB Index—a first-of-its-kind, narrative-based diagnostic tool that captures both quantitative and experiential data on uterine health conditions such as fibroids, endometriosis, and heavy menstrual bleeding.
This is complemented by an AI-enabled platform that supports multilingual data collection, real-time symptom tagging, and population-level insights, creating a new standard for how women’s health data is generated and used.
Menopause
Post-menopause memory decline linked to loss of oestrogen production in brain tissue – study

Oestrogen loss in brain tissue may help explain memory decline after menopause and women’s higher Alzheimer’s risk, a preclinical study suggests.
The findings suggest females may be especially sensitive to the loss of brain oestrogen in old age.
Scientists said the work could point to future treatments focused on restoring the brain’s supportive environment before memory loss develops.
Dr Hong Zhao, research professor of obstetrics and gynaecology in the division of reproductive science in medicine at Northwestern University Feinberg School of Medicine, said: “This study tells us that females, but not males, may be uniquely sensitive to loss of brain oestrogen at old age, potentially contributing to an increased risk of Alzheimer’s disease.”
Researchers at Northwestern University studied young and old male and female mice, with and without loss of brain oestrogen.
The study focused on the extracellular matrix, or ECM, a network of molecules in the space between brain cells. It helps support communication between cells and is important for memory, brain development and brain health. The ECM makes up nearly 20 per cent of the brain’s volume.
The ECM is especially abundant in the hippocampus, a part of the brain involved in learning and memory.
Scientists found that oestrogen loss, ageing and female sex were closely linked to changes in the ECM. The study is the first to examine oestrogen loss in the ECM.
The findings may help explain why women are at higher risk of Alzheimer’s disease, although the research was carried out in mice and further work is needed to understand whether the same mechanisms apply in humans.
Nearly two-thirds of people with Alzheimer’s disease in the US are women, but the reasons for this higher risk remain unclear.
Scientists have long suggested that falling oestrogen levels after menopause may reduce the brain’s natural protection against memory loss and neurodegeneration. Neurodegeneration means the gradual damage or loss of nerve cells in the brain.
Dr Serdar Bulun, chair of the department of obstetrics and gynaecology at Feinberg and a Northwestern Medicine physician, said: “We have provided some of the most compelling evidence that oestrogen is so important for memory function and other mood functions in the female brain.
“This should motivate clinicians to be more aware of the essential role of oestrogen for women’s brains, because once memory is gone, it’s gone.”
Before menopause, the ovaries are the main source of oestrogen in women. After menopause, oestrogen levels drop sharply, and only small amounts are produced in other parts of the body, including the brain, fat tissue, bone, muscle, blood vessels and breast tissue.
In mice, oestrogen is produced locally in the brain and gonadal fat in males, whereas in females it is produced mainly in the brain.
Research has shown that women with Alzheimer’s disease may have even lower oestrogen levels in the brain than women without the disease. The study further supports that.
The researchers used genetically engineered mouse models that lacked aromatase, an enzyme needed to produce oestrogen, either throughout the whole body or only in the brain.
They examined how the loss of oestrogen affected memory, behaviour and social function in male and female mice at young and old ages.
They also analysed changes in gene expression across the entire genome in the hippocampus in mice with brain-specific oestrogen loss at young and old ages in both sexes.
The authors said the findings suggest the ECM could become a target for future treatments.
Current Alzheimer’s treatments such as lecanemab and donanemab are designed to remove amyloid, an abnormal protein build-up in the brain that is one of the main signs of the disease.
However, researchers said it is still unclear how much these treatments help to slow memory loss or improve everyday functioning. Some studies suggest small benefits, while others show little meaningful improvement.
The study suggests a different approach could focus on restoring the brain’s supportive environment to help protect memory.
Zhao said: “Our findings will hopefully motivate future studies to better understand how this matrix is altered in postmenopausal women, and how it could potentially induce susceptibility to Alzheimer’s disease.”
Hormone replacement therapy, or HRT, has also been studied as a possible way to protect women from Alzheimer’s disease by restoring oestrogen levels.
However, clinical studies have produced mixed results, with some suggesting benefits for memory and cognitive function while others show little benefit or possible harm.
Zhao said differences may depend on the type of hormone treatment used, the age at which it begins and differences in study design.
She said: “More research is needed to understand how oestrogen affects the female brain and why oestrogen loss increases AD risk in women.
“Understanding these mechanisms could help researchers develop safer and more effective HRT strategies to prevent or slow the progression of AD in women.”
News
When sound drives wellness: Music’s expanding role in femtech

By Con Raso, Managing Director, Tuned Global
Music and technology leaders at Tuned Global, Endel and Bluesound Professional discuss intersection of art, tech, wellness and music.
The intersection of music and wellness is not new, but the shape of it is changing quickly.
Femtech innovation is evolving fast, and the decisions innovators make around content, technology, and licensing are creating a genuinely new kind of music business.
This space was explored during a panel at the 2025 Music Tectonics conference in Santa Monica, with other companies whose approaches to wellness music share very little in common beyond the category label.
The session, moderated by Andrew Stess, Head of Sales and Business Development for North America at music cloud platform Tuned Global, drew out a conversation between Graeme Harrison, Vice President & General Manager of Bluesound Professional, and Marina Guz, Chief Commercial Officer with Endel.
Stess opened with a deliberately broad question: what is wellness? The answers illustrated just how wide the category has become.
For context, Bluesound Professional makes networked audio hardware deployed across a range of environments, from gyms to hospitals to corporate offices.
The company works with services including Composure, which targets sleep improvement for people with dementia, and MoodSonic, which applies biophilic soundscaping to workplace environments.
“Wellness is different things to different services,” Bluesound Professional’s Harrison said.
“Fit Radio would look at wellness as being gyms and exercise and that sort of thing. Composure is about helping people with dementia, specifically sleep, go to sleep and stay asleep.
“With MoodSonic, wellness is all about the well workplace, getting well-certified and employee engagement, creating activity-based work where you can go to different areas of a workplace to achieve what you want; focus, relaxation, creativity, whatever.”
Endel’s Guz came at the question from a different angle.
The company generates AI-powered soundscapes for focus, relaxation, sleep and meditation, each personalised to the user’s biometric inputs.
“Can you sleep? Can you deal with stress? Are you grounded? What’s your general mindset towards things?” she said. “That’s what Endel is trying to really help you with.”
Art, Tech and Science

Marina Guz
For Endel, the music model is a little different from other music businesses.
Every soundscape is generated in real time, drawn from stems produced by Endel’s internal composers or in collaboration with external artists, and assembled dynamically based on user inputs including heart rate, time of day, weather, and movement.
“We always like to say we live at the intersection of tech, art, and science,” Guz said.
“The team has gone out and done a lot of research, we collaborate with a lot of scientists and researchers in the space to really understand what kind of sounds we need to play for you to fall asleep vs stay asleep vs when you wake up.”
The company’s founding team had musical backgrounds, including a neoclassical composer who has released on Decca, and a CEO whose deep interest in Brian Eno shaped the company’s foundational approach.
That grounding in composition distinguishes Endel’s output from what Guz sees as the broader wellness music category on streaming platforms.
The company’s first major artist collaboration was with Grimes. Since then it has worked with James Blake, Miguel, and others, building soundscapes that carry an artist’s sonic identity while adhering to scientific guidelines for the intended use case.
Endel was also, according to Guz, the first AI music company to sign deals with Universal Music Group and Warner Music Group.
The personalisation goes further than most listeners would expect.
Two people pressing play on the same Endel soundscape at the same time will hear different outputs, because the system continuously adapts to each user’s biometric state.
“If you and I, we’re in different locations, different age, different sex. Maybe you’re sitting down and walking around at different heart rates. Your soundscape will sound different than my soundscape because it will get personalised to the inputs that you give it,” Guz said.
“No track, no soundscape is ever the same in the app. It always gets generated on the fly for you in the moment based on the inputs.”
Hardware, Artists, and the AI Problem
Stess, whose work at Tuned Global is built around helping fitness, wellness and other companies navigate the complex music streaming and licensing space, steered the conversation toward implementation. The theory was covered.

Andrew Stess
What does the infrastructure look like in practice, and where do artists fit in it?
Harrison brought up the delivery layer, something the panel hadn’t dwelled on yet.
Bluesound Professional makes networked audio hardware that sits at the endpoint of everything the other two companies build, and there’s more going on there than the word “hardware” suggests.
Their devices are individually addressable network speakers, which means a service like MoodSonic can pull in real-time occupancy levels, temperature, and time of day to shift a workplace soundscape on the fly.
Their work with Composure goes further, using pillow sensors to measure sleep quality in dementia patients and adapting the audio output accordingly.
Harrison also raised something that landed quietly in the room: Model Context Protocol.
Developed initially by Anthropic and later adopted by OpenAI, Microsoft, and Google, it’s a standard that lets agentic AI communicate directly with connected devices.
When he asked who in the audience knew what it was, only a handful of hands went up.
“It completely subverts the controller interface,” he said.
“That means that we can control all of our devices via our AI agent of choice.”
On the question of where artists fit, Stess put it directly: how do you build something sustainable in wellness? Guz’s answer was blunt.
Much of the wellness streaming world runs on ghost producers and fake artist profiles built to generate playlist placements rather than careers.
“It’s all kind of ghost producers, fake artists that populate these playlists,” she said.
“On that side of the world, there can still be a lot done to promote more artists who want to actually move into the space.”
Endel is now launching Sources, a label dedicated to artist-centric wellness music, signing neoclassical and ambient artists who make the music but lack the platform.

Graeme Harrison
“We are signing just small artists, because there are a lot of amazing neoclassical artists who make music in the space, but they don’t really have a platform,” Guz said.
“We’re launching something that is really just humans making music for the space, no science, no tech, no anything, because that’s what’s really missing, at least on the streaming side of the business.”
Guz also flagged a complication specific to Endel.
The company has worked with AI since before it became a loaded term, and that history has become a liability.
The early collaborations with Grimes, James Blake, and Miguel drew real attention when generative soundscapes with named artists were still a novelty.
That novelty has since been swamped by a flood of low-effort AI-generated content filling wellness playlists across every major platform.
“AI is associated, especially in the wellness space, with slop,” she said.
“So much content, cover artwork, is being generated, and everything looks terrible and a lot of it sounds terrible, and so we are being grouped into that same thing, even though we’re really not [that] at all”
The questions the panel kept returning to, around licensing, metadata, artist engagement, and the AI content quality problem, are the sort Tuned Global works through with clients building music into health and wellness products.
The wellness music space is growing, the licensing challenges are real, and the opportunity for artists willing to engage seriously with it is there.
The infrastructure, whether hardware, soundscape technology, or a fitness platform’s back end, is further along than most of the music industry has noticed.
About Con Raso, Managing Director of Tuned Global
Con Raso is an entrepreneur passionate about innovation, new technologies, and start-ups.
Over the last few decades he has focused on creating innovative mobile and online distribution models within the B2C entertainment market, enabling brands to utilise music as a marketing tool, via unique customer engagement strategies.
Being inherently well-versed in both technology and music, Con ensures our solutions are aesthetically pleasing, engaging and disruptive.
About Tuned Global
Tuned Global is the data-driven music cloud platform that empowers businesses to integrate commercial music into their apps and launch complete streaming experiences using advanced APIs, real-time analytics, licensing solutions, rights management systems, Ai-enabled music discovery, and customisable white-label streaming apps.
Our turnkey solutions for music, audio, and video — coupled with advanced AI capabilities and a broad ecosystem of third-party music tech integrations — make us the most comprehensive platform for powering any digital music project.
We streamline complexities in licensing, rights management, and content delivery, enabling rapid innovation and bringing new ideas to life. Since 2011, we’ve supported 40+ companies in 70+ countries — across telecom, gaming, fitness, health, media, aviation, and more — to deliver innovative music experiences faster and more cost-effectively.
Learn more at tunedglobal.com
News4 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Insight4 weeks agoWhy the UK’s fertility rate keeps falling – and what it means if you’re trying now
Wellness4 weeks agoWomen’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage
Opinion3 weeks agoWhat Maternal Mental Health Month reveals about where postpartum support actually breaks down
Fertility4 weeks agoToxins and climate harms having ‘alarming’ effect on fertility, research warns
Insight3 weeks agoNIH Grant terminations disproportionately impact minority scientists, research finds
Adolescent health3 weeks agoWUKA brings Period-Positive Pool Party to London Aquatics Centre to keep girls swimming through puberty
Fertility4 weeks agoResearcher explores weight loss jab impact on PCOS













Pingback: Femtech company becomes first foetal ultrasound start-up using AI to get FDA clearance - FemTech World